STUDY OBJECTIVES: Autosomal dominant cerebellar ataxia, deafness and narcolepsy (ADCA-DN) is caused by DNMT1 mutations. Diagnosing the syndrome can be difficult, as all clinical features may not be present at onset, HLA-DQB1*06:02 is often negative, and sporadic cases occur. We report on clinical and genetic findings in a 31-year-old woman with cerebellar ataxia, deafness, and narcolepsy, and discuss diagnostic challenges. DESIGN: Clinical and genetic investigation in a patient and family members. SETTING: Ataxia clinic, São Paulo, Brazil. PATIENTS OR PARTICIPANTS: One patient and her family members. INTERVENTIONS: N/A. MEASUREMENTS AND RESULTS: Narcolepsy was supported by polysomnographic and multiple sleep latency testing. HLA-DQB1*06:02 was positive. CSF hypocretin-1 was 191 pg/mL (normal values > 200 pg/mL). Mild brain atrophy was observed on MRI, with cerebellar involvement. The patient, her asymptomatic mother, and 3 siblings gave blood samples for genetic analysis. DNMT1 exons 20 and 21 were sequenced. Haplotyping of polymorphic markers surrounding the mutation was performed. The proband had a novel DNMT1 mutation in exon 21, p.Cys596Arg, c.1786T > C. All 4 parental haplotypes could be characterized in asymptomatic siblings without the mutation, indicating that the mutation is de novo in the patient. CONCLUSIONS: The Brazilian patient reported here further adds to the worldwide distribution of ADCA-DN. The mutation is novel, and illustrates a sporadic case with de novo mutation. We believe that many more cases with this syndrome are likely to be diagnosed in the near future, mandating knowledge of this condition and consideration of the diagnosis.
STUDY OBJECTIVES:Autosomal dominant cerebellar ataxia, deafness and narcolepsy (ADCA-DN) is caused by DNMT1 mutations. Diagnosing the syndrome can be difficult, as all clinical features may not be present at onset, HLA-DQB1*06:02 is often negative, and sporadic cases occur. We report on clinical and genetic findings in a 31-year-old woman with cerebellar ataxia, deafness, and narcolepsy, and discuss diagnostic challenges. DESIGN: Clinical and genetic investigation in a patient and family members. SETTING:Ataxia clinic, São Paulo, Brazil. PATIENTS OR PARTICIPANTS: One patient and her family members. INTERVENTIONS: N/A. MEASUREMENTS AND RESULTS:Narcolepsy was supported by polysomnographic and multiple sleep latency testing. HLA-DQB1*06:02 was positive. CSF hypocretin-1 was 191 pg/mL (normal values > 200 pg/mL). Mild brain atrophy was observed on MRI, with cerebellar involvement. The patient, her asymptomatic mother, and 3 siblings gave blood samples for genetic analysis. DNMT1 exons 20 and 21 were sequenced. Haplotyping of polymorphic markers surrounding the mutation was performed. The proband had a novel DNMT1 mutation in exon 21, p.Cys596Arg, c.1786T > C. All 4 parental haplotypes could be characterized in asymptomatic siblings without the mutation, indicating that the mutation is de novo in the patient. CONCLUSIONS: The Brazilian patient reported here further adds to the worldwide distribution of ADCA-DN. The mutation is novel, and illustrates a sporadic case with de novo mutation. We believe that many more cases with this syndrome are likely to be diagnosed in the near future, mandating knowledge of this condition and consideration of the diagnosis.
Entities:
Keywords:
Narcolepsy; cerebellar ataxia; de novo; deafness; novel DNMT1 mutation
Authors: K Hojo; T Imamura; M Takanashi; K Ishii; M Sasaki; S Imura; R Ozono; Y Takatsuki; S Takauchi; E Mori Journal: Eur J Neurol Date: 1999-05 Impact factor: 6.089
Authors: A Melberg; J Hetta; N Dahl; I Nennesmo; M Bengtsson; R Wibom; C Grant; K H Gustavson; P O Lundberg Journal: J Neurol Sci Date: 1995-12 Impact factor: 3.181
Authors: Barry A Chestnut; Qing Chang; Ann Price; Catherine Lesuisse; Margaret Wong; Lee J Martin Journal: J Neurosci Date: 2011-11-16 Impact factor: 6.167
Authors: Juliane Winkelmann; Ling Lin; Barbara Schormair; Birgitte R Kornum; Juliette Faraco; Giuseppe Plazzi; Atle Melberg; Ferdinando Cornelio; Alexander E Urban; Fabio Pizza; Francesca Poli; Fabian Grubert; Thomas Wieland; Elisabeth Graf; Joachim Hallmayer; Tim M Strom; Emmanuel Mignot Journal: Hum Mol Genet Date: 2012-02-09 Impact factor: 6.150
Authors: Leah K Hutnick; Peyman Golshani; Masakasu Namihira; Zhigang Xue; Anna Matynia; X William Yang; Alcino J Silva; Felix E Schweizer; Guoping Fan Journal: Hum Mol Genet Date: 2009-05-10 Impact factor: 6.150
Authors: Christopher J Klein; Maria-Victoria Botuyan; Yanhong Wu; Christopher J Ward; Garth A Nicholson; Simon Hammans; Kaori Hojo; Hiromitch Yamanishi; Adam R Karpf; Douglas C Wallace; Mariella Simon; Cecilie Lander; Lisa A Boardman; Julie M Cunningham; Glenn E Smith; William J Litchy; Benjamin Boes; Elizabeth J Atkinson; Sumit Middha; P James B Dyck; Joseph E Parisi; Georges Mer; David I Smith; Peter J Dyck Journal: Nat Genet Date: 2011-05-01 Impact factor: 38.330
Authors: Jonathan Baets; Xiaohui Duan; Yanhong Wu; Gordon Smith; William W Seeley; Inès Mademan; Nicole M McGrath; Noah C Beadell; Julie Khoury; Maria-Victoria Botuyan; Georges Mer; Gregory A Worrell; Kaori Hojo; Jessica DeLeon; Matilde Laura; Yo-Tsen Liu; Jan Senderek; Joachim Weis; Peter Van den Bergh; Shana L Merrill; Mary M Reilly; Henry Houlden; Murray Grossman; Steven S Scherer; Peter De Jonghe; Peter J Dyck; Christopher J Klein Journal: Brain Date: 2015-02-11 Impact factor: 13.501
Authors: Susan Helm; Morgan Blayney; Taylor Whited; Mahjabin Noroozi; Sen Lin; Semira Kern; David Green; Ahmad Salehi Journal: Front Cell Neurosci Date: 2017-06-09 Impact factor: 5.505